Skip to search formSkip to main contentSkip to account menu

CGS 16617

Known as: CGS-16617 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

libenzapril

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Intra- and Intersubject Variability: Mixed-Effects Statistical Analysis of Repeated Doses of an Angiotensin Converting Enzyme Inhibitor, CGS 16617
The intrasubject and intersubject variabilities for CGS 16617, an angiotensin converting enzyme inhibitor, were evaluated in an… 
1988
1988
Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617.
Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617 were evaluated in anesthetized dogs. Intravenous… 
1987
1987
Additive Beneficial Effects of Two Inhibitors of Vasoconstrictor Mediators in Acute Myocardial Ischemia 1
Abstract A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-12970, a new angiotensin-converting enzyme (ACE) inhibitor… 
1985
1985
Effect of Food on the Bioavailability of Pentopril, an Angiotensin‐Converting‐Enzyme Inhibitor, in Healthy Subjects
Pentopril (CGS 13945) was administered in 125‐mg capsules to eight healthy men on two occasions according to a randomized… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)